PMC:7405836 / 87091-87356 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T290","span":{"begin":36,"end":44},"obj":"Body_part"},{"id":"T291","span":{"begin":115,"end":123},"obj":"Body_part"}],"attributes":[{"id":"A290","pred":"fma_id","subj":"T290","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A291","pred":"fma_id","subj":"T291","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"The contributions of the structural proteins, like spike (S), matrix (M), small envelope (E), and nucleocapsid (N) proteins, of SARS-CoV to induce protective immunity has been evaluated by expressing them in a recombinant parainfluenza virus type 3 vector (BHPIV3)."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T810","span":{"begin":128,"end":136},"obj":"Disease"},{"id":"T811","span":{"begin":128,"end":132},"obj":"Disease"}],"attributes":[{"id":"A810","pred":"mondo_id","subj":"T810","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A811","pred":"mondo_id","subj":"T811","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"The contributions of the structural proteins, like spike (S), matrix (M), small envelope (E), and nucleocapsid (N) proteins, of SARS-CoV to induce protective immunity has been evaluated by expressing them in a recombinant parainfluenza virus type 3 vector (BHPIV3)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T817","span":{"begin":167,"end":170},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T818","span":{"begin":208,"end":209},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T819","span":{"begin":236,"end":241},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"}],"text":"The contributions of the structural proteins, like spike (S), matrix (M), small envelope (E), and nucleocapsid (N) proteins, of SARS-CoV to induce protective immunity has been evaluated by expressing them in a recombinant parainfluenza virus type 3 vector (BHPIV3)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T52094","span":{"begin":36,"end":44},"obj":"Chemical"},{"id":"T6277","span":{"begin":115,"end":123},"obj":"Chemical"}],"attributes":[{"id":"A49493","pred":"chebi_id","subj":"T52094","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A19936","pred":"chebi_id","subj":"T6277","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"The contributions of the structural proteins, like spike (S), matrix (M), small envelope (E), and nucleocapsid (N) proteins, of SARS-CoV to induce protective immunity has been evaluated by expressing them in a recombinant parainfluenza virus type 3 vector (BHPIV3)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T608","span":{"begin":0,"end":265},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The contributions of the structural proteins, like spike (S), matrix (M), small envelope (E), and nucleocapsid (N) proteins, of SARS-CoV to induce protective immunity has been evaluated by expressing them in a recombinant parainfluenza virus type 3 vector (BHPIV3)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"2427","span":{"begin":51,"end":56},"obj":"Gene"},{"id":"2431","span":{"begin":128,"end":136},"obj":"Species"},{"id":"2432","span":{"begin":222,"end":248},"obj":"Species"},{"id":"2436","span":{"begin":98,"end":110},"obj":"Gene"}],"attributes":[{"id":"A2427","pred":"tao:has_database_id","subj":"2427","obj":"Gene:43740568"},{"id":"A2431","pred":"tao:has_database_id","subj":"2431","obj":"Tax:694009"},{"id":"A2432","pred":"tao:has_database_id","subj":"2432","obj":"Tax:11216"},{"id":"A2436","pred":"tao:has_database_id","subj":"2436","obj":"Gene:43740575"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"The contributions of the structural proteins, like spike (S), matrix (M), small envelope (E), and nucleocapsid (N) proteins, of SARS-CoV to induce protective immunity has been evaluated by expressing them in a recombinant parainfluenza virus type 3 vector (BHPIV3)."}